107 related articles for article (PubMed ID: 12375035)
1. Assessment of carcinoma in the sublingual region based on magnetic resonance imaging.
Asaumi J; Shigehara H; Konouchi H; Yanagi Y; Hisatomi M; Matsuzaki H; Kishi K
Oncol Rep; 2002; 9(6):1283-7. PubMed ID: 12375035
[TBL] [Abstract][Full Text] [Related]
2. MR factor analysis: improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumors.
Eida S; Ohki M; Sumi M; Yamada T; Nakamura T
J Magn Reson Imaging; 2008 Jun; 27(6):1256-62. PubMed ID: 18504743
[TBL] [Abstract][Full Text] [Related]
3. [Value of manifestations of magnetic resonance imaging (MRI) in diagnosis of parotid tumors and their pathological bases].
Yuan JP; Liang BL; Xie BK; Song ZC; Zhong JL
Ai Zheng; 2003 May; 22(5):514-9. PubMed ID: 12753715
[TBL] [Abstract][Full Text] [Related]
4. The value of dynamic contrast-enhanced MRI in diagnosis of malignant lymphoma of the head and neck.
Asaumi J; Yanagi Y; Hisatomi M; Matsuzaki H; Konouchi H; Kishi K
Eur J Radiol; 2003 Nov; 48(2):183-7. PubMed ID: 14680911
[TBL] [Abstract][Full Text] [Related]
5. Relationships between dynamic contrast-enhanced MRI findings and pattern of invasion for tongue carcinoma.
Ariyoshi Y; Shimahara M
Oncol Rep; 2006 May; 15(5):1339-43. PubMed ID: 16596208
[TBL] [Abstract][Full Text] [Related]
6. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of dynamic magnetic resonance imaging for salivary gland diseases: a preliminary study.
Suenaga S; Indo H; Noikura T
Dentomaxillofac Radiol; 2001 Nov; 30(6):314-8. PubMed ID: 11641729
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors.
Hisatomi M; Asaumi J; Yanagi Y; Unetsubo T; Maki Y; Murakami J; Matsuzaki H; Honda Y; Konouchi H
Oral Oncol; 2007 Oct; 43(9):940-7. PubMed ID: 17257881
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
10. Assessment of MRI and dynamic contrast-enhanced MRI in the differential diagnosis of adenomatoid odontogenic tumor.
Asaumi J; Yanagi Y; Konouchi H; Hisatomi M; Matsuzaki H; Shigehara H; Kishi K
Eur J Radiol; 2004 Sep; 51(3):252-6. PubMed ID: 15294333
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
Zhou ZR; Shen TZ; Chen XR; Peng WJ
Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
[TBL] [Abstract][Full Text] [Related]
12. Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors.
Tsuda N; Kato N; Murayama C; Narazaki M; Yokawa T
Invest Radiol; 2004 Feb; 39(2):80-8. PubMed ID: 14734922
[TBL] [Abstract][Full Text] [Related]
13. [Value of dynamic enhanced magnetic resonance in diagnosis of pancreatic carcinoma and endocrine tumors].
Lu GM; Wang ZQ; Zheng L; Wang JP; Qiu XM; Tang XJ
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):951-4. PubMed ID: 16759532
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
[TBL] [Abstract][Full Text] [Related]
15. Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck.
Asaumi J; Yanagi Y; Konouchi H; Hisatomi M; Matsuzaki H; Kishi K
Oral Oncol; 2004 Jul; 40(6):579-84. PubMed ID: 15063385
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
17. Prediction of early response to radiotherapy of uterine carcinoma with dynamic contrast-enhanced MR imaging using pixel analysis of MR perfusion imaging.
Takayama Y; Ohno T; Kishimoto R; Kato S; Yoneyama R; Kandatsu S; Tsujii H; Obata T
Magn Reson Imaging; 2009 Apr; 27(3):370-6. PubMed ID: 18768283
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
19. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
20. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]